SCIENTIFIC HUB

Follow the evidence.

106.818 articles found

Open access

Parkinsonism disrupts cortical function by dysregulating oscillatory, network and synaptic activity of parvalbumin positive interneurons.

Minetti A, Montagni E, Meneghetti N, Macchi F, Coulomb É, Martello A, Tiberi A, Capsoni S, Mazzoni A, Allegra Mascaro AL, Spalletti C.

NPJ Parkinsons Dis · 2025-07-01

DOI: 10.1038/s41531-025-01052-6PMID: 40593705

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson's disease trials.

Pagano G, Trundell D, Simuni T, Pavese N, Marek K, Postuma RB, Shariati N, Monnet A, Moore E, Davies EW, Svoboda H, Pross N, Bonni A, Nikolcheva T, PASADENA Investigators, Prasinezumab Study Group.

NPJ Parkinsons Dis · 2025-07-01

DOI: 10.1038/s41531-025-01041-9PMID: 40593721

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Digital speech biomarkers can measure acute effects of levodopa in Parkinson's disease.

Sousa M, Krýže P, Amstutz D, Petermann K, Averna A, Castelli M, Magalhães AD, Jorge A, Švihlík J, Tykalová T, Illner V, Maradan-Gachet ME, Diamantaras AA, Waskönig J, Lachenmayer ML, Debove I, Tinkhauser G, Nef T, Rusz J, Krack P.

NPJ Parkinsons Dis · 2025-07-01

DOI: 10.1038/s41531-025-01045-5PMID: 40593773

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.